Straumann BLX Implant System

Implant, Endosseous, Root-form

Institut Straumann AG

The following data is part of a premarket notification filed by Institut Straumann Ag with the FDA for Straumann Blx Implant System.

Pre-market Notification Details

Device IDK173961
510k NumberK173961
Device Name:Straumann BLX Implant System
ClassificationImplant, Endosseous, Root-form
Applicant Institut Straumann AG Peter Merian Weg 12 Basel,  CH Ch-4002
ContactViviana Horhoiu
CorrespondentJennifer M. Jackson
Straumann USA, LLC 60 Minuteman Road Andover,  MA  01810
Product CodeDZE  
CFR Regulation Number872.3640 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2017-12-28
Decision Date2018-06-05
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.